Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also ...

Some people are not taking weight-loss medications responsibly, the physician says, and don't realize their full implications ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

What's the difference between Wegovy and Ozempic? The main difference between the two are what the FDA has approved them for. “While Wegovy and Ozempic both contain semaglutide, Wegovy is FDA ...

The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.

Weight-loss medications surged in popularity this year. A survey from Kaiser Family Foundation found one in eight adults have ...

AS GLP-1 AGONISTS soar in popularity—about 12 percent of the U.S. population has tried one, most often Ozempic or Wegovy ...

The growing popularity of GLP-1 receptor agonists—including Ozempic and Wegovy from Novo Nordisk, and Mounjaro and Zepbound ...

Ozempic, Wegovy, and other GLP-1 receptor agonists have become a game-changer in obesity treatment, but their high ...

The growing popularity of GLP-1 receptor agonists—including Ozempic and Wegovy from Novo Nordisk ... for GLP-1 medications ...